Key result
Prolonged low-dose cangrelor safely manages thrombosis in a patient with concurrent stroke, PE, and STEMI.
Why the study?
Antithrombotic therapy in acute patients with both high ischaemic and bleeding risks remains challenging.
Case Report (n=1)
Prolonged cangrelor bridging at a reduced dose may be a safe and effective option for patients requiring P2Y12 inhibition who have both high ischaemic and high bleeding risks.
Answers are grounded in this paper and cite their sources.
May support cangrelor bridging in select high-risk cases; hypothesis-generating and requires prospective validation before practice change.
Background: Antithrombotic therapy in acute patients with both high ischaemic and bleeding risks remains challenging. Case summary: We presented a challenging case involving a 48-year-old man referred to our hospital for headache and a left superior quadrantanopia. A CT scan revealed a right inferior occipital lobe ischaemic stroke. During the hospital stay, the patients developed pulmonary embolism (PE), and ST-elevation myocardial infarction (STEMI). A triple antithrombotic therapy was indicated, but the patient presented with high bleeding (anaemia, active malignancy, ischaemic stroke) and ischaemic (ischaemic stroke, PE, and superimposed STEMI) risks. In this critical acute setting, prolonged cangrelor infusion of reduced dosage, coupled with aspirin and enoxaparin, proved an effective and safe antithrombotic approach. Discussion: Prolonged cangrelor bridging at a reduced dose of 0.75 μg/kg/min may represent an effective and safe option in acute patients requiring P2Y12 inhibition and presenting both high ischaemic and high bleeding risks.
No takes yet. Share an insight, caveat, or question.
Oliveri et al. (2024) conducted a case report in Concomitant ischaemic stroke, pulmonary embolism, and ST-elevation myocardial infarction (n=1). Cangrelor was evaluated. Prolonged cangrelor infusion at a reduced dose of /kg/min was an effective and safe antithrombotic approach in a patient with concomitant ischaemic stroke, PE, and STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: